emerging dilemmas in statin use: incident diabetes, hiv dyslipidemia, and drug-drug interactions
DESCRIPTION
Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions. Program Goals. Get With The Guidelines. The Framingham Study. Copenhagen Male Study: Risk of Ischemic Heart Disease (IHD) Associated With Higher TG and Lower HDL-C. Intensive Statin Therapy. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/1.jpg)
Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia,
and Drug-Drug Interactions
![Page 2: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/2.jpg)
![Page 3: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/3.jpg)
Program Goals
![Page 4: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/4.jpg)
Get With The Guidelines
![Page 5: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/5.jpg)
The Framingham Study
![Page 6: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/6.jpg)
Copenhagen Male Study: Risk of Ischemic Heart Disease (IHD) Associated With Higher TG and
Lower HDL-C
![Page 7: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/7.jpg)
Intensive Statin Therapy
![Page 8: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/8.jpg)
Guideline Recommendations
![Page 9: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/9.jpg)
Approximate Dose Equivalency of Statin LDL-C Efficacy
![Page 10: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/10.jpg)
The Statin Armamentarium: Individual Metabolism
Characteristics
![Page 11: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/11.jpg)
CYP Inhibitors: Drug-Drug Interactions
![Page 12: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/12.jpg)
Statin Use in Diabetes: Cardiovascular Events
![Page 13: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/13.jpg)
Effect of Statins on New-onset T2D
![Page 14: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/14.jpg)
JUPITER: Rosuvastatin and New-Onset T2D
![Page 15: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/15.jpg)
Glucose Control: Differential Influence of Statins
![Page 16: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/16.jpg)
J-PREDICT: Pitavastatin May Reduce New-Onset T2D
![Page 17: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/17.jpg)
Dyslipidemia in HIV
![Page 18: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/18.jpg)
Statins and HAART Drug-Drug Interactions
![Page 19: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/19.jpg)
Lipid-Lowering Therapy in HIV
![Page 20: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/20.jpg)
Glucose Control in HIV
![Page 21: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/21.jpg)
INTREPID: Effects of Pitavastatin vs Pravastatin in HIV Dyslipidemia
![Page 22: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/22.jpg)
Summary
![Page 23: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/23.jpg)
Abbreviations
![Page 24: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/24.jpg)
Abbreviations (cont)
![Page 25: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/25.jpg)
References
![Page 26: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/26.jpg)
References (cont)
![Page 27: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/27.jpg)
References (cont)
![Page 28: Emerging Dilemmas in Statin Use: Incident Diabetes, HIV Dyslipidemia, and Drug-Drug Interactions](https://reader035.vdocuments.site/reader035/viewer/2022062310/56815ecf550346895dcd58b7/html5/thumbnails/28.jpg)
References (cont)